Administration's 2013 Budget Could Discourage Development of Cures and Breakthrough Medicines, Limit Patient Choice And Forestall Job Growth

WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Obama’s FY 2013 budget proposal released yesterday: “While BIO supports the broad goals of the President Obama’s FY2013 budget, many of the provisions included in the proposal jeopardize continued biotech research and development that will lead to cures and breakthrough medicines for patients worldwide living with debilitating diseases. Th

Feed Date: 
February 14, 2012